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Background:  Epigenetic  modiﬁcations,  particularly  DNA  methylation  and  posttranslational
histone  modiﬁcations  regulate  heritable  changes  in transcription  without  changes  in  the
DNA sequence.  Despite  a number  of studies  showing  clear links between  environmental
factors  and DNA  methylation,  little  is known  about  the  effect  of  environmental  factors
on  the recently  identiﬁed  histone  lysine  methylation.  Since  their  identiﬁcation  numerous
studies  have  establish  critical  role  played  by these  enzymes  in  mammalian  development.
Objectives: Identiﬁcation  of  the  Jumonji  (Jmj)  domain  containing  histone  lysine  demethy-
lase  have  added  a new  dimension  to epigenetic  control  of gene  expression  by dynamic
regulation  of histone  methylation  marks.  The  objective  of  our  study  was  to evaluate  the
effect  of prohexadione  and  trinexapac,  widely  used  plant  growth  regulators  of  the  acylcy-
clohexanediones  class,  on the  enzymatic  activity  of histone  lysine  demethylases  and  histone
modiﬁcations  during  the  neural  stem/progenitor  cell differentiation.
Methods: Here  we  show  that  prohexadione,  but not  trinexapac,  directly  inhibits  non-heme
iron (II), 2-oxoglutarate-dependent  histone  lysine  demethylase  such  as  Jmjd2a.  We  used
molecular modeling  to  show  binding  of  prohexadione  to Jmjd2a.  We  also performed  in vitro
demethylation  assays  to show  the  inhibitory  effect  of  prohexadione  on  Jmjd2a.  Further  we
tested this  molecule  in cell culture  model  of  mouse  hippocampal  neural  stem/progenitor
cells  to demonstrate  its effect  toward  neuronal  proliferation  and  differentiation.
Results: Molecular  modeling  studies  suggest  that  prohexadione  binds  to the 2-oxoglutarate
binding  site of  Jmjd2a  demethylase.  Treatment  of  primary  neural  stem/progenitor  cells  with
prohexadione showed  a concentration  dependent  reduction  in  their  proliferation.  Further,
the prohexadione  treated  neurospheres  were  induced  toward  neurogenic  lineage  upon
differentiation.
Conclusions:  Our  results  d
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. Introduction
Epigenetics dictates the foundation of cellular growth,
ifferentiation, and identity. They are regulated by covalent
odiﬁcations of the genomic DNA, particularly methyla-
ion  at carbon-5 of cytosine residues located in the CpG
slands, and post-translational modiﬁcations of histones. A
umber  of exogenous factors can inﬂuence the cellular epi-
enetics  and cause heritable changes in gene expression
ithout changing the genomic DNA sequence by manip-
lating the cellular DNA methylation patterns. Results
rom a number of studies have established an associa-
ion between DNA methylation and environmental metals
ncluding cadmium, lead, nickel, and arsenic [1,2]. In addi-
ion,  environmental chemicals such as trichloroethylene,
ichloroacetic acid, trichloroacetic acid, benzene, etc. can
lso  inﬂuence epigenetics by changing the DNA methyla-
ion  [3–5].
Eukaryotic histones, around which the genomic DNA is
rapped, also undergo extensive post-translational mod-
ﬁcations  which regulate epigenetics by controlling the
ccessibility and usage of the genomic DNA. As a result, his-
one  modifying enzymes, speciﬁcally those that modulate
cetylation and methylation, play a vital role in the trans-
riptional regulation of genes. Histones are methylated on
he  lysine or arginine residues. The predominant sites of
ysine  methylation include histone-3 lysine-4 (H3-K4), H3-
9,  H3-K27, H3-K36, H3-K79 and H4-K20 [6]. For a long
ime,  histone methylation marks were considered to be
tatic.  However, identiﬁcation of lysine-speciﬁc demethy-
ase  1 (LSD1, which can only demethylate mono- and
i-methylated H3-K4 and H3-K9) and a number of Jumonji
Jmj)  domain containing iron (II), 2-oxoglutarate (2OG)-
ependent histone lysine demethylases (KDMs, which
an  even demethylate tri-methylated lysine residues of
istone)  have added a new dimension to the dynamic epi-
enetic  regulation [7]. Despite a number of studies showing
lear  links between environmental factors and DNA meth-
lation,  little is known about the effect of environmental
actors on histone lysine methylation.
Prohexadione (3,5-dioxo-4-propionylcyclohexanecar-
oxylic  acid) and trinexapac [4-(cyclopropylhydroxy-
ethylene)-3,5-dioxocyclohexanecarboxylic acid] are
lant  growth regulators (PGRs) of the acylcyclohexane-
iones class. Trinexapac–ethyl (an ester form, also known
s  Primo/Cimectacarb/Cimetacarb) is one of the most
ommonly used PGR on ﬁne turf surfaces throughout
he world; while prohexadione–calcium (a salt form,
lso known as Apogee/Baseline) inhibits the synthesis of
ibberellins, a naturally occurring plant hormone, and is
 widely used chemical for controlling vegetative growth.
t  is also sprayed on apple and pear leaves, which inhibits
avanone 3-hydroxylase and ﬂavonol synthase resulting
n  changes in the ﬂavonoid spectrum. This results in an
nhanced resistance of apple and pear leaves toward two
ajor  pome fruit diseases, ﬁre blight (caused by Erwinia
mylovora) and apple scab (caused by Venturia inaequalis)
8,9]. Due to structural similarities between prohexadione
nd trinexapac to 2OG, it has been proposed that acylcy-
lohexanediones such as prohexadione enhance resistance
y  inhibiting iron (II), 2OG-dependent dioxygenases (e.g.orts 1 (2014) 1152–1161 1153
ﬂavanone  3-hydroxylase and ﬂavonol synthase) which
play  important roles in ﬂavonoid biosynthesis [10]. There-
fore,  we  hypothesized that these two  PGRs may  inhibit
iron (II), 2OG-dependent KDMs and modulate epigenetics
in  mammalian cells. Here, we provide evidence that
prohexadione, but not trinexapac, potently inhibits KDMs
and  modulates epigenetics in cell-based studies.
2. Materials and methods
2.1.  Preparation of Jmjd2a protein and ligands for
docking studies
The  Jmjd2a protein has been crystallized at pH 5.5, and
the  structure was solved at 2.15 A˚ resolution [11]. This X-
ray  crystal structure of Jmjd2a protein (PDB code: 2OQ7)
was  used for docking studies. This structure of Jmjd2a
protein represents a catalytically inactive enzyme since
the  normal cofactors iron (II) and 2OG were replaced by
Ni(II)  and N-oxalylglycine, a competitive inhibitor of 2OG-
dependent dioxygenases. Therefore, the inhibitory Ni(II)
was  replaced by iron (II) in the active site, and the Jmjd2a
protein preparation for docking studies was  carried out
using  protein preparation wizard (PPW) of Schrodinger’s
Suite 2012. The water molecules were removed from this
structure, and the “het states” for the iron (II) and N-
oxalylglycine were generated at pH 5.5 (pH at which
crystallization was carried out) and pH 7.5 (pH at which
Jmjd2a enzymatic assays were carried out in this study)
using Epik [12,13]. Epik is a program which predicts the pKa
values of ionizable groups in small molecules/ligands (e.g.
N-oxalylglycine, prohexadione etc.) at a pH or within a pH
range.  In the reﬁnement stage of PPW, all the added hydro-
gen  atoms in the prepared structure of the Jmjd2a protein
were  minimized, and the H-bond optimization was carried
out  using protonation states of residues at pH 5.5 and 7.5.
The  pKa values of amino acid residues at a given pH were
calculated using PROPKA [14]. Finally, a restrained mini-
mization of Jmjd2a structure was  carried out using OPLS
2005  force ﬁeld.
For  the preparation of ligands for docking studies,
the two-dimensional (2D) structures of N-oxalylglycine,
prohexadione, and trinexapac were drawn. These 2D struc-
tures  were converted to 3D structures, which generated
R/S-stereoisomers of prohexadione and trinexapac, at pH
5.5  and 7.5 using ligprep (LigPrep, version 2.5, Schrödinger,
LLC, New York, NY, 2012) and Epik (Epik, version 2.3,
Schrödinger, LLC, New York, NY, 2012).
2.2. Docking of ligands to Jmjd2a protein
Ligands prepared at pH 5.5 and 7.5 were docked to
Jmjd2a protein prepared at pH 5.5 and 7.5, respectively. A
docking  region, also known as the grid, was  centered on the
template  ligand (i.e. N-oxalylglycine of the prepared Jmjd2a
protein)  with a default box size of 26 A˚ × 21 A˚ × 24 A˚. The
docking calculations were carried out using Glide in the
extra  precision (XP) mode [15]. Glide does ﬂexible ligand
docking into a rigid protein structure by sampling of
logy Rep1154 D.T. Vavilala et al. / Toxico
positional, orientational, and conformational degrees of
freedom  of the ligand.
2.3.  Cloning, expression and puriﬁcation of Jmjd2a
Jumonji domain containing region of Jmjd2a gene
was cloned, expressed, and puriﬁed as described ear-
lier  [16,17], with minor modiﬁcations. In brief, the
N-terminal GST tag containing fusion Jmjd2a enzyme in
pGEX-4T1 expression vector (GE Healthcare, Piscataway,
NJ) was puriﬁed from Escherichia coli BL21 (DE3) cells,
using afﬁnity chromatography. The chromatographic frac-
tions  containing puriﬁed Jmjd2a enzyme was dialyzed in
25  mM NaCl (Sigma–Aldrich, St. Louis, MO), 25 mM HEPES
(Sigma–Aldrich), pH 7.5 for ≈8 h. The dialyzed Jmjd2a pro-
tein  was stored in 15% glycerol at –80 ◦C.
2.4. In vitro demethylation assay
The in vitro Jmjd2a demethylation assays were carried
out in triplicates as described earlier [11]. All the assays
were carried out in 50 l reaction volume. The in vitro reac-
tions  were performed in 25 mM HEPES buffer at pH 7.5
by  adding the substrate solution to the enzyme solution
and incubating for 30 min. The enzyme solution contained
2  M of puriﬁed Jmjd2a, 3 M FeSO4 and 20 M ascor-
bate in 25 mM HEPES buffer and the substrate solution
contained 6 M 2OG and 10 M of the peptide substrate
in 25 mM HEPES buffer. The enzyme solution was incu-
bated  at room temperature for 15 min  in the absence or
presence of 1 mM inhibitors i.e. N-oxalylglycine (Frontier
Scientiﬁc, Logan, UT), prohexadione (Chem Service, West
Chester,  PA) and trinexapac (Crescent Chemical Company,
Islandia, NY) before the substrate solution was added. The
reaction  was stopped by adding 50 l of methanol, fol-
lowed by the addition of 100 l of 80 mM tri-ammonium
citrate. Further, the reaction mixture was centrifuged
using an Eppendorf 5417C centrifuge at 13,000 rpm for
2  min.
2.5.  Demethylation assay analysis using matrix
associated laser desorption ionization-time of ﬂight
(MALDI-TOF)
The supernatant (5 l) from the above reaction
mixture was added to 5 l of the matrix i.e. -cyano-4-
hydroxycinnamic acid (CHCA, Sigma–Aldrich). From the
above  mixture, 1 l was spotted in triplicates on a MALDI
plate (pre-spotted with 1 l of matrix) for analysis using
a  MALDI-TOF instrument. All spectra were collected on a
Voyager  DE PRO MALDI-TOF mass spectrometer (Applied
Biosystems, Foster City, CA). Spectra for each sample was
obtained by averaging 500 laser shots. Data were collected
in  triplicates to capture the variability related to demeth-
ylation reaction, sample preparation, data collection, and
data  extraction during MALDI analysis. Only one represen-
tative spectrum under each assay condition (e.g. with or
without  inhibitor) is shown in Fig. 1.orts 1 (2014) 1152–1161
2.6. Mouse neural stem/progenitor cell culture,
neurosphere imaging and analysis
Mouse hippocampal neural stem/progenitor cells
(NSCs/NPCs) were harvested and cultured according to our
previous  study [18]. Brieﬂy, postnatal day 3 (P3) C57BL/6
female mice pups were euthanized by decapitation and
hippocampi were dissected out, minced, and triturated in
0.025%  trypsin–EDTA for 7 min  at 37 ◦C. Activity of trypsin
was  arrested by the addition of 0.014% trypsin inhibitor
containing 1 mg/ml  DNase-1 (Gibco, Carlsbad, CA). The
isolated  cells were pelleted down at 700 × g for 5 min
and resuspended in NeuroCult NSC basal media (Stem-
cell  Technologies, Vancouver, BC, Canada). The basal media
contained 1× mouse proliferative supplement (Stemcell
Technologies), 100 U/ml penicillin, 40 g/ml streptomycin,
0.02% BSA (Calbiochem, San Diego, CA), 10 ng/ml basic
ﬁbroblast growth factor (Sigma–Aldrich), 20 ng/ml epider-
mal  growth factor (Calbiochem), and 0.04 mg/ml  heparin
(Sigma–Aldrich). Single cell suspensions were obtained
by passing the resuspended cells through a 40 m ﬁl-
ter.  Isolated cells were seeded in a 96-well plate to
form neurospheres. Prohexadione and trinexapac–ethyl
(Chem Service, West Chester, PA) were dissolved in DMSO
and  sterile water, respectively. For the cell-based stud-
ies  trinexapac–ethyl, instead of trinexapac, was  used to
enhance its cell permeability. After its transport inside the
cells,  it is de-esteriﬁed by cellular esterases [19], to gen-
erate  trinexapac. Neurosphere cultures were treated with
1,  1.5, and 2 mM of PGRs along with solvent controls for
a  period of 6 days. At the end of day 6, neurospheres
were imaged using Zeiss Axiovert 200 M Live Cell Work-
station. The size and the number of neurospheres were
analyzed using Axiovision LE Rel 4.3 software by taking
images of four random ﬁelds per well at 10× magniﬁca-
tion. The neurospheres were plated in chambered cover
glass  (ThermoFisher Lab-Tek, Waltham, MA)  and induced
for  differentiation into neurons and glia by transferring
them to differentiation medium. The differentiation media
contsisted of Neurocult NSC basal medium with 1% FBS
(Gibco), 100 U/ml penicillin, 40 g/ml streptomycin, and
0.02%  BSA. PGRs along with solvent controls were added in
the  differentiation media. The differentiation was induced
for  5 days, after which images of four random ﬁelds per
well  at 10× magniﬁcation were captured. The sizes and
numbers of neurospheres were analyzed using Axiovision
LE  Rel 4.3 software. All animal procedures were approved
by  the Institutional Animal Ethics Committee (IAEC) of
the  Centre for Cellular and Molecular Biology (CCMB),
Hyderabad, Andhra Pradesh, India (IAEC/CCMB/Protocol
No. 25/2011).
2.7. Immunoﬂuorescence studies
Neurospheres upon differentiation were immuno-
stained using standard procedures. Brieﬂy, cells were
ﬁxed with 4% paraformaldehyde in 1× PBS for 10 min
and  permeabilized with 1× PBS containing 0.3% Triton
X-100 for 90 min. After treating the differentiated cells
in  the blocking solution (5% BSA in 1× PBS containing
0.3% TritonX-100) for 2 h at room temperature, cells were
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Fig. 1. Mass spectra (MALDI-TOF) of Jmjd2a catalyzed demethylation reactions using H3-K9me3 peptide as substrate in the absence (a), or presence of N-oxalylglycine (b), prohexadione (c), and trinexapac (d).
logy Reports 1 (2014) 1152–1161
Table 1
Name of ligands used for docking experiments using ligprep and Epik with
their  docking scores at the indicated pH values.
Ligand name Docking score
at  pH 5.5
Docking  score
at  pH 7.5
N-oxalylglycine −11.5 kcal/mol −9.6 kcal/mol
R-prohexadione −10.1  kcal/mol −8.2 kcal/mol1156 D.T. Vavilala et al. / Toxico
incubated overnight at 4 ◦C in the blocking solution con-
taining following primary antibodies: mouse anti-neuronal
nuclei or NeuN (Millipore, Billerica, MA)  at 1:100 dilution,
rabbit anti-glial ﬁbrillary acidic protein or GFAP (Abcam,
Cambridge, MA)  at 1:1000 dilution, rabbit anti-H3-K9me2
(Millipore) at 1:1000 dilution, rabbit anti-H3-K27me2
(Abcam) at 1:1000 dilution, and rabbit anti-H3-K36me2
(Abcam) at 1:1000 dilution. After 3 washes with 1× PBS,
cells  were incubated with appropriate secondary antibod-
ies:  Cy3 conjugated goat anti-rabbit IgG (Abcam) at 1:1000
dilution and Alexaﬂuor 488 conjugated goat anti-mouse
IgG (Life Technologies, Grand Island, NY) at 1:500 dilu-
tion.
2.8.  Statistical analysis
Students’s  t-test was performed to evaluate the strength
of  signiﬁcance. To evaluate the effect of prohexadione
treatment on neural stem/progenitor cells (NSCs/NPCs)
proliferation and/or differentiation, the ‘Fisher’s Exact’
statistical test was performed because the sample size
(number of experimental replicates) was less than ten. This
analysis  was performed to evaluate the neurosphere size
distribution in each experimental group. The total num-
ber  of neurospheres were considered as 100%. P values
less  than 0.05 were considered as signiﬁcant difference. All
statistical  analysis was carried out using GraphPad Prism
Software.
3.  Results and discussions
3.1.  Prohexadione and trinexapac bind at the 2OG
binding site of Jmjd2a demethylase
Due to structural similarities between 2OG, pro-
hexadione, and trinexapac it has been proposed that
prohexadione and trinexapac act as competitive inhibitors
of  2OG-dependent enzymes in the gibberellin biosynthetic
pathway. Therefore, we  hypothesized that prohexadione
and trinexapac may  bind at the active site of recently
characterized KDMs. In humans ∼25–30 putative Jmj
domain containing iron (II), 2OG-dependent KDMs have
been  identiﬁed that are classiﬁed into 7 families based
on  their sequences [6,7]. Since the protein puriﬁcation,
enzymatic assay, and crystal structure of the jumonji
domain-2 (Jmjd2) family KDMs are documented in the
literature [11,16,17], we focused on Jmjd2a isoform as a
representative KDM for docking and in vitro enzymatic
studies.
For in silico experiments, the 3D output structures of
ligands (e.g. N-oxalylglycine, prohexadione, and trinexa-
pac)  generated at pH 5.5 and 7.5 (Fig. S1), were docked
to  the Jmjd2a protein prepared at pH 5.5 and 7.5, respec-
tively. The output structures of N-oxalylglycine at both
pH  5.5 and 7.5 were the same. Docking of the ligands
at the Jmjd2a active site gave the best docking scores
(–11.5 kcal/mol and −9.6 kcal/mol at pH 5.5 and 7.5, respec-
tively) for N-oxalylglycine, which is structurally similar to
Jmjd2a  co-substrate/natural ligand, 2OG. Since the crys-
tal  structure of the substrate bound Jmjd2a demethylase
was solved with 2OG structural analog, N-oxalylglycineS-prohexadione −10.3  kcal/mol −9.3 kcal/mol
R-trinexapac −10.2 kcal/mol −8.3 kcal/mol
S-trinexapac −9.4 kcal/mol −7.6 kcal/mol
(instead of 2OG [11], to trap the enzyme in an inactive
form), for comparison we performed our docking experi-
ments with N-oxalylglycine and not 2OG. The docking pose
of  N-oxalylglycine was  very similar to its co-crystallized
structure with Jmjd2a [11] (Fig. S2), validating our docking
protocol.
A  conversion of 2D input structures of prohexadione
and trinexapac into 3D output structure generated R/S-
stereoisomers (Fig. S1). It is important to note that both
prohexadione and trinexapac are available and used in
the  environment as racemic mixtures containing both
R/S-stereoisomers. Therefore, we performed our docking
experiments with both the enantiomers. Although, N-
oxalylglycine binds to iron (II) at the Jmjd2a catalytic site
in  a bidentate fashion, both the stereoisomers of prohexa-
dione and trinexapac bind in a monodentate manner at
pH  5.5 and 7.5 (Figs. S3–S5). This may account for lower
docking scores for prohexadione and trinexapac stereoiso-
mers, compared to N-oxalylglycine, at both pH 5.5 and 7.5
(Table  1). The docking scores of all the ligands were lower
at  pH 7.5 compared to pH 5.5. This could be due to the
electrostatic award which was  more favorable when the
ligands  were docked to the Jmjd2a protein prepared at pH
5.5.  In general, docking scores and ligand efﬁciency (i.e.
docking score/number of heavy atoms) were best for N-
oxalylglycine followed by prohexadione (R-prohexadione
–10.1 kcal/mol and –8.2 kcal/mol at pH 5.5 and 7.5, respec-
tively; S-prohexadione –10.3 kcal/mol and –9.3 kcal/mol
at pH 5.5 and 7.5, respectively) and then by trinexa-
pac (R-trinexapac –10.2 kcal/mol and –8.3 kcal/mol at pH
5.5  and 7.5, respectively; S-trinexapac –9.4 kcal/mol and
–7.6  kcal/mol at pH 5.5 and 7.5, respectively) (Table 1).
Our  docking experiments suggest that prohexadione and
trinexapac, to a lesser extent, may  inhibit Jmjd2a, and pos-
sibly  other KDMs, by directly binding at the 2OG binding
site  in the active site of KDMs.
Prohexadione inhibits the activity of Jmjd2a demethylase
in vitro
Jmjd2a demethylates tri-methylated H3-K9 (H3-
K9me3), H3-K9me2, and H3-K36me3 [11]. In order to test
our  hypothesis that prohexadione and trinexapac act as
general  inhibitors of recently identiﬁed KDMs, Jmjd2a
was  puriﬁed to homogeneity and assayed for the ability
of  different chemicals e.g. N-oxalylglycine, prohexadione,
and trinexapac to inhibit the demethylation of H3-K9me3
into the dimethylated product, H3-K9me2. The results
showed that in the absence of N-oxalylglycine and PGRs,
Jmjd2a efﬁciently converted H3-K9me3 peptide into
D.T. Vavilala et al. / Toxicology Reports 1 (2014) 1152–1161 1157
Fig. 2. Live-cell imaging of neurospheres treated with different concentrations of prohexadione (a), trinexapac–ethyl (b), and the size-range of neurospheres
treated  with different concentrations of prohexadione (c). Fisher’s exact test was performed to evaluate the effects of prohexadione on the proliferation
of  neural stem/progenitor cells. P values less than 0.05 were considered as signiﬁcant difference compared to DMSO/vehicle treated control sample and
marked  as *.
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H3-K9me2 (Fig. 1a). However, in the presence of 1 mM
N-oxalylglycine, a known inhibitor of iron (II), 2OG-
dependent KDMs, no product formation was  detected
(Fig. 1b). These results suggest that our assay conditions
are suitable for inhibition studies using prohexadione and
trinexapac. The presence of 1 mM prohexadione in the
reaction mixture completely abrogated the conversion
of H3-K9me3 peptide substrate into H3-K9me2 product
(Fig.  1c). However, under the same assay condition only a
partial  inhibition of Jmjd2a catalytic activity was observed
by  trinexapac (Fig. 1d). Although our studies were per-
formed with the racemic mixture of trinexapac, which
contains both R/S-stereoisomers, a limited inhibition
by trinexapac could be due to poor the docking score,
especially for the S-trinexapac (–7.6 kcal/mol) at pH 7.5,
at  which the enzymatic assays were performed. These
results demonstrate that prohexadione, and trinexapac
to  some extent, directly inhibit the catalytic activity of
Jmjd2a  demethylase.
Fig. 3. Immunoﬂuorescence staining for H3-K27me2 in differentiated neural stem
for  H3-K36me2 in differentiated neural stem cell cultures treated with prohexa
H3-K27me2  (c), and H3-K36me2 (d) in differentiated neural stem cell cultures trorts 1 (2014) 1152–1161
3.2.  Prohexadione inhibits the proliferation of
neurospheres
Next, the effects of prohexadione and trinexapac on
KDMs were evaluated using neurosphere cultures. Neuro-
spheres are used to study the proliferation, self-renewal,
and multi-potency of NSCs/NPCs [20], where KDMs play
critical  roles [21–23]. For example, formation of large neu-
rospheres reﬂects good neurogenic potential of NSCs/NPCs
[24]. Therefore, the mouse NSCs/NPCs were treated with
different concentrations of prohexadione and trinexapac,
and the proliferation of neurospheres were measured.
For these studies, the sizes of neurospheres were divided
into  three different groups: small (<50 m),  medium
(50–100 m),  and large (>100 m). In the DMSO treated
control samples 44.93% neurospheres were small, 51.89%
were  medium, and 3.17% were large in size. Consistent
with the results of our docking and in vitro enzymatic
experiments, trinexapac treated NSCs/NPCs did not show
 cell cultures treated with prohexadione (a), immunoﬂuorescence staining
dione (b). Graphical representation of immunoﬂuorescence staining for
eated with various dose of prohexadione.
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ny apparent change in the number, morphology, or size
f  neurospheres (Fig. 2a). However, with an increase in
he  prohexadione concentration, the size distribution of
eurospheres were 53.14% small and 46.85% medium
t  1 mM;  74.83% small and 25.16% medium at 1.5 mM;
nd  75.81% small and 24.18% medium at 2 mM (Figs. 2b
nd  c). Interestingly, large neurospheres normally seen in
eurosphere assays, 3.17% in this case, were completely
bsent from the prohexadione treated groups, while the
umbers  of neurospheres in the smaller size range were
levated, indicating an inhibition of neurosphere prolif-
ration (Fig. 2c). Thus, consistent with our docking and
ig. 4. Immunoﬂuorescence staining for the neuronal mark NeuN upon different
ione.orts 1 (2014) 1152–1161 1159
biochemical studies, administration of selected PGRs of
the  acylcyclohexanediones class had different effect on
the  growth of neural stem/progenitor cells (NSCs/NPCs),
as shown in Fig. 2. Trinexapac, which doesn’t block the
Jmjd2a demethylase activity, fails to affect the growth
potential of NSCs/NPCs. On the other hand prohexadione,
which blocks the Jmjd2a demethylase activity, signiﬁ-
cantly reduces the growth potential of NSCs/NPCs in a dose
dependent manner (Fig. 2). Taken together, our results
indicate a clear correlation between the inhibition of
demethylase activity and the stem cell growth by selected
PGRs.
iation of the neural stem/progenitor cell cultures treated with prohexa-
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3.3. Prohexadione acts by increasing the methylation on
H3-K27  and H3-K36 residues
Finally,  we evaluated if prohexadione-mediated inhibi-
tion  of neurosphere proliferation is mediated via inhibition
of  demethylation on H3-K9, H3-K27 and H3-K36 sites
by  immunoﬂuorescence studies. To this end, no signiﬁ-
cant  change was observed in the methylation status of
H3-K9me2 mark (data not shown); however, the H3-
K27me2 and H3-K36me2 levels increased with an increase
in  the concentration of prohexadione (Fig. 3). These stud-
ies  indicate that prohexadione likely acts in vivo by
inhibiting H3-K27 and H3-K36 speciﬁc demethylases (e.g.
Jmjd3  and Jmjd2a) [25]. Since the dynamic histone lysine
methylations, particularly of H3-K27 residue, play criti-
cal  roles in neural stem cell proliferation, stem-ness and
differentiation [21–23], we evaluated the cellular fate of
prohexadione treated neurospheres by immunoﬂuores-
cence studies using antibodies for neuronal nuclei or NeuN,
a  neuronal marker, and for glial ﬁbrillary acidic protein or
GFAP,  a glial marker. Interestingly, these studies showed
that  prohexadione treated neurospheres had a concentra-
tion dependent increase in the expression of NeuN (Fig. 4),
suggesting  that these neurospheres were induced toward
neurogenic lineage upon differentiation. Taken together,
our  results establish that prohexadione modulates prolifer-
ation  and differentiation of neurospheres possibly by acting
as  a general inhibitor of histone lysine demethylases.
4. Conclusion
According to the World Health Organization annually
more than 13 million deaths are attributed to envi-
ronmental causes, and ≈24% of the diseases caused by
environmental pollutants can be avoided. During the
course of our study, it was shown that daminozide (also
known as Alar), selectively inhibits KDM2/7 demethylases
[26]. Daminozide, another 2OG analog and PGR similar
to  prohexadione, was sprayed on apple trees until 1989,
before it was withdrawn due to concerns of its effect
on  human health. Prohexadione has been classiﬁed as a
reduced  risk pesticide by the Environmental Protection
Agency due to its low toxicity and limited persistence in
the  environment due to photo and microbial degradations
[9,27]. Although it meets the reduced risk criteria for pes-
ticides,  our results described in this article indicates that
it  is essential to set a stringent ‘Maximum Residue Limits’
for  prohexadione to promote its safe use for food pro-
duction. Our results warrant further investigation into the
effects  of long-term exposure of prohexadione on epige-
netic  changes associated with neuronal development [25].
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